Charles Sturt University
Graham Centre for Agricultural Innovation

Rice bran arabinoylan compound study

This study is examining if a rice bran supplement improves the quality of life of cancer patients during treatment.

Rice bran arabinoxylan compound (RBAC) is a food supplement known to affect the body’s ability to defend against germs and cancerous cells.

During cancer treatment, RBAC may also help to reduce side effects, make patients feel better, and may improve treatment results.

However, there hasn't been enough research done to prove this. This study will examine whether RBAC does provide benefits during cancer treatment.

What does the clinical trial involve?

Researchers are seeking participants who are aged 18 years or older, who have been diagnosed with cancer (stage II and above) and are currently receiving cancer treatment.

Participants will take either the supplement or dummy powder for six months and will also be asked to complete the following items five times during the study:

  • Online questionnaires
  • blood tests
  • body scans
  • stool sample collections

How can people take part in the clinical trial?

The study will be carried out at three locations:

LocationPrincipal InvestigatorTrial resources

Daffodil Cottage Cancer Service - Bathurst Health Service

365 Howick St, West Bathurst NSW 2795

Dr Rob Zielinski
(02) 6369 3380
Rob.Zielinski@health.nsw.gov.au

Central West Cancer Centre - Orange Health Service

1502 Forest Road, Orange, NSW 2800

Dr Rob Zielinski
(02) 6369 3380
Rob.Zielinski@health.nsw.gov.au

Chris O'Brien Lifehouse

119-143 Missenden Road, Camperdown NSW 2050

Associate Professor  Judith Lacey
(02) 8514 0038
Judith.lacey@lh.org.au

Express your interest in taking part

If you are interested in taking part in this trial, please fill in our expression of interest form.

Yes I am interested

For more information about the wider study

For for more information please contact:

Dr Sok Cheon Pak
Lead Researcher 
Phone: (02) 6338 4952
Email: spak@csu.edu.au

Publications relating to this research

Ooi, S. L., Pak, S. C., Micalos, P. S., Schupfer, E., Lockley, C., Park, M. H., & Hwang, S.-J. (2021). The health-promoting properties and clinical applications of rice bran arabinoxylan modified with shiitake mushroom enzyme—A narrative review. Molecules, 26(9), 2539. https://doi.org/10.3390/molecules26092539

Schupfer, E., Pak, S. C., Wang, S., Micalos, P. S., Jeffries, T., Ooi, S. L., Golombick, T., Harris, G., & El-Omar, E. (2021). The effects and benefits of arabinoxylans on human gut microbiota – A narrative review. Food Bioscience, 43, 101267. https://doi.org/https://doi.org/10.1016/j.fbio.2021.101267

Ooi, S. L., Pak, S. C., Micalos, P. S., Schupfer, E., Zielinski, R., Jeffries, T., Harris, G., Golombick, T., & McKinnon, D. (2020). Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial. Contemporary Clinical Trials Communications, 19,100580. https://doi.org/10.1016/j.conctc.2020.100580